Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Bellezza

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Clinical Lung Cancer|October 22, 2013
Clinical outcome with platinum-based chemotherapy in patients with advanced nonsquamous EGFR wild-type non-small-cell lung cancer segregated according to KRAS mutation statusGiulio Metro, Rita Chiari, Chiara Bennati, et al.
Archives of Biochemistry and Biophysics|May 24, 2024
Subcellular distribution and Nrf2/Keap1-interacting properties of Glutathione S-transferase P in hepatocellular carcinomaDesirée Bartolini, Anna Maria Stabile, Anna Migni, et al.
Molecular and Clinical Oncology|December 15, 2018
<i>KRAS</i> mutation and DNA repair and synthesis genes in non-small-cell lung cancerVienna Ludovini, Biagio Ricciuti, Francesca R Tofanetti, et al.
Journal of Cancer|June 7, 2021
INSL4 as prognostic marker for proliferation and invasiveness in Non-Small-Cell Lung CancerDamiano Scopetti, Danilo Piobbico, Cinzia Brunacci, et al.
Oncotarget|June 26, 2018
Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitorsEwa Rupniewska, Rajat Roy, Francesco A Mauri, et al.
American Journal of Clinical Oncology|March 26, 2015
MYC and human telomerase gene (TERC) copy number gain in early-stage non-small cell lung cancerAntonella Flacco, Vienna Ludovini, Fortunato Bianconi, et al.
Oncotarget|November 16, 2017
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot studyVienna Ludovini, Rita Chiari, Lorenzo Tomassoni, et al.
Lung Cancer (Amsterdam, Netherlands)|September 24, 2015
Clinical impact of sequential treatment with ALK-TKIs in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter analysisRita Chiari, Giulio Metro, Daniela Iacono, et al.
Tumori|August 19, 2008
Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic TumorsVienna Ludovini, Lorenza Pistola, Vanesa Gregorc, et al.
Oncotarget|October 16, 2015
Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumorsElisa Baldelli, Guido Bellezza, Eric B Haura, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Clinical Lung Cancer|October 22, 2013
Clinical outcome with platinum-based chemotherapy in patients with advanced nonsquamous EGFR wild-type non-small-cell lung cancer segregated according to KRAS mutation statusGiulio Metro, Rita Chiari, Chiara Bennati, et al.
Archives of Biochemistry and Biophysics|May 24, 2024
Subcellular distribution and Nrf2/Keap1-interacting properties of Glutathione S-transferase P in hepatocellular carcinomaDesirée Bartolini, Anna Maria Stabile, Anna Migni, et al.
Molecular and Clinical Oncology|December 15, 2018
<i>KRAS</i> mutation and DNA repair and synthesis genes in non-small-cell lung cancerVienna Ludovini, Biagio Ricciuti, Francesca R Tofanetti, et al.
Journal of Cancer|June 7, 2021
INSL4 as prognostic marker for proliferation and invasiveness in Non-Small-Cell Lung CancerDamiano Scopetti, Danilo Piobbico, Cinzia Brunacci, et al.
Oncotarget|June 26, 2018
Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitorsEwa Rupniewska, Rajat Roy, Francesco A Mauri, et al.
American Journal of Clinical Oncology|March 26, 2015
MYC and human telomerase gene (TERC) copy number gain in early-stage non-small cell lung cancerAntonella Flacco, Vienna Ludovini, Fortunato Bianconi, et al.
Oncotarget|November 16, 2017
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot studyVienna Ludovini, Rita Chiari, Lorenzo Tomassoni, et al.
Lung Cancer (Amsterdam, Netherlands)|September 24, 2015
Clinical impact of sequential treatment with ALK-TKIs in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter analysisRita Chiari, Giulio Metro, Daniela Iacono, et al.
Tumori|August 19, 2008
Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic TumorsVienna Ludovini, Lorenza Pistola, Vanesa Gregorc, et al.
Oncotarget|October 16, 2015
Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumorsElisa Baldelli, Guido Bellezza, Eric B Haura, et al.
Pageof 11